🕵️ Allogene Therapeutics, Inc. ($ALLO)
SEC insider & ownership activity, last 12 months · CIK 1737287 · every row links its SEC filing
Over the last 12 months insiders sold $603K with no open-market buying against it. David D. Chang sold $289K in discretionary trades (Feb–Mar). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 6 sellers, $603K (14 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| David D. Chang | 0 | – | 2 | $289K | Mar 16, 2026 |
| Zachary J Roberts | 0 | – | 2 | $104K | Feb 2, 2026 |
| Geoffrey M. Parker | 0 | – | 2 | $88K | Feb 2, 2026 |
| Beneski Benjamin Machinas | 0 | – | 5 | $52K | Mar 31, 2026 |
| Earl Douglas | 0 | – | 1 | $40K | Feb 2, 2026 |
| Yoshiyama Annie | 0 | – | 2 | $29K | Apr 21, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Pfizer Inc. | 9.0% | 13D | Nov 6, 2025 | filing ↗ | |
| ARIE Belldegrun, M.D. | 5.4% | 13G | May 13, 2026 | filing ↗ | |
| Blackrock, Inc. | 5.3% | 13G | Apr 17, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Yoshiyama Annie | $22K | Apr 21, 2026 | filing ↗ |
| Beneski Benjamin Machinas | $7K | Apr 1, 2026 | filing ↗ |
| Beneski Benjamin Machinas | $12K | Mar 16, 2026 | filing ↗ |
| David D. Chang | $118K | Mar 16, 2026 | filing ↗ |
| Beneski Benjamin Machinas | $19K | Mar 2, 2026 | filing ↗ |
| Earl Douglas | $40K | Feb 2, 2026 | filing ↗ |
| Geoffrey M Parker | $42K | Feb 2, 2026 | filing ↗ |
| Zachary J Roberts | $63K | Feb 2, 2026 | filing ↗ |
| Annie T Yoshiyama | $7K | Feb 2, 2026 | filing ↗ |
| David Chang | $439K | Feb 2, 2026 | filing ↗ |
| Benjamin M Beneski | $29K | Feb 2, 2026 | filing ↗ |
| Roberts Zachary | $41K | Jan 21, 2026 | filing ↗ |
| Beneski Benjamin Machinas | $959 | Nov 17, 2025 | filing ↗ |
| Geoffrey M. Parker | $46K | Oct 21, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jun 18, 2026 | filing ↗ |
| Other events (8.01) | Jun 18, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 28, 2026 | filing ↗ |
| Material agreement (1.01) | May 12, 2026 | filing ↗ |
| Agreement terminated (1.02) | May 12, 2026 | filing ↗ |
| Earnings (2.02) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Other events (8.01) | Apr 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 14, 2026 | filing ↗ |
| Other events (8.01) | Apr 13, 2026 | filing ↗ |
| Other events (8.01) | Apr 13, 2026 | filing ↗ |
| Earnings (2.02) | Mar 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 12, 2026 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Other events (8.01) | Sep 26, 2025 | filing ↗ |
| Earnings (2.02) | Aug 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 13, 2025 | filing ↗ |
| Other events (8.01) | Aug 1, 2025 | filing ↗ |